Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

102 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Blood-based protein biomarkers for diagnosis of Alzheimer disease.
Doecke JD, Laws SM, Faux NG, Wilson W, Burnham SC, Lam CP, Mondal A, Bedo J, Bush AI, Brown B, De Ruyck K, Ellis KA, Fowler C, Gupta VB, Head R, Macaulay SL, Pertile K, Rowe CC, Rembach A, Rodrigues M, Rumble R, Szoeke C, Taddei K, Taddei T, Trounson B, Ames D, Masters CL, Martins RN; Alzheimer's Disease Neuroimaging Initiative; Australian Imaging Biomarker and Lifestyle Research Group. Doecke JD, et al. Among authors: macaulay sl. Arch Neurol. 2012 Oct;69(10):1318-25. doi: 10.1001/archneurol.2012.1282. Arch Neurol. 2012. PMID: 22801742 Free PMC article.
A blood-based predictor for neocortical Aβ burden in Alzheimer's disease: results from the AIBL study.
Burnham SC, Faux NG, Wilson W, Laws SM, Ames D, Bedo J, Bush AI, Doecke JD, Ellis KA, Head R, Jones G, Kiiveri H, Martins RN, Rembach A, Rowe CC, Salvado O, Macaulay SL, Masters CL, Villemagne VL; Alzheimer’s Disease Neuroimaging Initiative; Australian Imaging, Biomarkers and Lifestyle Study Research Group. Burnham SC, et al. Among authors: macaulay sl. Mol Psychiatry. 2014 Apr;19(4):519-26. doi: 10.1038/mp.2013.40. Epub 2013 Apr 30. Mol Psychiatry. 2014. PMID: 23628985
Prognostic serum miRNA biomarkers associated with Alzheimer's disease shows concordance with neuropsychological and neuroimaging assessment.
Cheng L, Doecke JD, Sharples RA, Villemagne VL, Fowler CJ, Rembach A, Martins RN, Rowe CC, Macaulay SL, Masters CL, Hill AF; Australian Imaging, Biomarkers and Lifestyle (AIBL) Research Group. Cheng L, et al. Among authors: macaulay sl. Mol Psychiatry. 2015 Oct;20(10):1188-96. doi: 10.1038/mp.2014.127. Epub 2014 Oct 28. Mol Psychiatry. 2015. PMID: 25349172
Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study.
Villemagne VL, Burnham S, Bourgeat P, Brown B, Ellis KA, Salvado O, Szoeke C, Macaulay SL, Martins R, Maruff P, Ames D, Rowe CC, Masters CL; Australian Imaging Biomarkers and Lifestyle (AIBL) Research Group. Villemagne VL, et al. Among authors: macaulay sl. Lancet Neurol. 2013 Apr;12(4):357-67. doi: 10.1016/S1474-4422(13)70044-9. Epub 2013 Mar 8. Lancet Neurol. 2013. PMID: 23477989
Pupil response biomarkers for early detection and monitoring of Alzheimer's disease.
Frost S, Kanagasingam Y, Sohrabi H, Bourgeat P, Villemagne V, Rowe CC, Macaulay SL, Szoeke C, Ellis KA, Ames D, Masters CL, Rainey-Smith S, Martins RN; AIBL Research Group. Frost S, et al. Among authors: macaulay sl. Curr Alzheimer Res. 2013 Nov;10(9):931-9. doi: 10.2174/15672050113106660163. Curr Alzheimer Res. 2013. PMID: 24117119
Plasma amyloid-β levels are significantly associated with a transition toward Alzheimer's disease as measured by cognitive decline and change in neocortical amyloid burden.
Rembach A, Watt AD, Wilson WJ, Villemagne VL, Burnham SC, Ellis KA, Maruff P, Ames D, Rowe CC, Macaulay SL, Bush AI, Martins RN, Masters CL, Doecke JD; AIBL Research Group. Rembach A, et al. Among authors: macaulay sl. J Alzheimers Dis. 2014;40(1):95-104. doi: 10.3233/JAD-131802. J Alzheimers Dis. 2014. PMID: 24334723
Predicting Alzheimer disease with β-amyloid imaging: results from the Australian imaging, biomarkers, and lifestyle study of ageing.
Rowe CC, Bourgeat P, Ellis KA, Brown B, Lim YY, Mulligan R, Jones G, Maruff P, Woodward M, Price R, Robins P, Tochon-Danguy H, O'Keefe G, Pike KE, Yates P, Szoeke C, Salvado O, Macaulay SL, O'Meara T, Head R, Cobiac L, Savage G, Martins R, Masters CL, Ames D, Villemagne VL. Rowe CC, et al. Among authors: macaulay sl. Ann Neurol. 2013 Dec;74(6):905-13. doi: 10.1002/ana.24040. Ann Neurol. 2013. PMID: 24448836 Free article.
Alzheimer's disease cerebrospinal fluid biomarkers are not influenced by gravity drip or aspiration extraction methodology.
Rembach A, Evered LA, Li QX, Nash T, Vidaurre L, Fowler CJ, Pertile KK, Rumble RL, Trounson BO, Maher S, Mooney F, Farrow M, Taddei K, Rainey-Smith S, Laws SM, Macaulay SL, Wilson W, Darby DG, Martins RN, Ames D, Collins S, Silbert B, Masters CL, Doecke JD; AIBL Research Group. Rembach A, et al. Among authors: macaulay sl. Alzheimers Res Ther. 2015 Nov 19;7(1):71. doi: 10.1186/s13195-015-0157-7. Alzheimers Res Ther. 2015. PMID: 26581886 Free PMC article.
Predicting Alzheimer disease from a blood-based biomarker profile: A 54-month follow-up.
Burnham SC, Rowe CC, Baker D, Bush AI, Doecke JD, Faux NG, Laws SM, Martins RN, Maruff P, Macaulay SL, Rainey-Smith S, Savage G, Ames D, Masters CL, Wilson W, Villemagne VL. Burnham SC, et al. Among authors: macaulay sl. Neurology. 2016 Sep 13;87(11):1093-101. doi: 10.1212/WNL.0000000000003094. Epub 2016 Aug 17. Neurology. 2016. PMID: 27534714
Concordance Between Cerebrospinal Fluid Biomarkers with Alzheimer's Disease Pathology Between Three Independent Assay Platforms.
Doecke JD, Rembach A, Villemagne VL, Varghese S, Rainey-Smith S, Sarros S, Evered LA, Fowler CJ, Pertile KK, Rumble RL, Trounson B, Taddei K, Laws SM, Macaulay SL, Bush AI, Ellis KA, Martins R, Ames D, Silbert B, Vanderstichele H, Masters CL, Darby DG, Li QX, Collins S; AIBL Research Group. Doecke JD, et al. Among authors: macaulay sl. J Alzheimers Dis. 2018;61(1):169-183. doi: 10.3233/JAD-170128. J Alzheimers Dis. 2018. PMID: 29171991
102 results